No implication of thromboxane prostanoid receptors in reactive hyperemia of skin and skeletal muscle in human forearm
| Autor: | Lucas Liaudet, Bernard Waeber, Antoine Pasche, Abigael Heim, François Feihl |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Thromboxane Hyperemia 030204 cardiovascular system & hematology Naphthalenes Receptors Thromboxane A2 Prostaglandin H2 03 medical and health sciences Thromboxane A2 chemistry.chemical_compound Young Adult 0302 clinical medicine Forearm Double-Blind Method Internal medicine medicine.artery medicine Laser-Doppler Flowmetry Humans Brachial artery Muscle Skeletal Reactive hyperemia 030304 developmental biology Skin Pharmacology 0303 health sciences Cross-Over Studies business.industry Skeletal muscle Prostanoid 3. Good health Plethysmography medicine.anatomical_structure Endocrinology Terutroban chemistry cardiovascular system Cardiology Propionates Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | J Cardiovasc Pharmacol |
| ISSN: | 1533-4023 |
| Popis: | There is evidence that reactive hyperemia (ie, the transient increase of blood flow above resting level after a short period of ischemia) could be negatively modulated by vasoconstrictor prostanoids. The present study tested whether pharmacological blockade of the thromboxane prostanoid receptors with the specific antagonist S18886 (terutroban) would amplify reactive hyperemia in human skin and skeletal muscle. Twenty healthy young male volunteers were enrolled in a randomized, blinded, crossover trial of oral S18886 30 mg/d for 5 days versus placebo. Reactive hyperemia was evaluated in forearm skin and skeletal muscle, after occlusion of the brachial artery with a pneumatic cuff inflated at suprasystolic pressure. Blood flow was measured with laser Doppler imaging (skin) and strain gauge venous occlusion plethysmography (muscle). On the first and last day of each treatment period, recordings of reactive hyperemia were obtained immediately before and 2 hours after drug intake. Whether in forearm muscle or skin, S18886 had no discernible effect on peak postocclusion blood flow, nor on the global hyperemic response as quantified by the area under curve. These results do not support that thromboxane prostanoid receptor activation could exert a moderating influence on reactive hyperemia in human skin and skeletal muscle, at least in young subjects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|